By comparing sensitive vs acquired IB-R cells, we have defined IB-R as FOXO3a/PTEN/AKT-dependent in CLL and DLBCL in the absence of BTK or PLCG2 mutations. The gene discussed is PTEN; the disease is B-cell chronic lymphocytic leukemia.